|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23.09.26 - 09:12
|
TempraMed gibt Vertriebsvereinbarung mit CenterWell Pharmacy®, der Pharmadienstleistungsmarke von Humana, bekannt (IRW Press)
|
|
|
Toronto, ON / 23. September 2026 / IRW-Press / TempraMed Technologies Ltd. (CSE: VIVI) (FWB: 9DY) (OTCQB: TMPTF) („TempraMed“ oder das „Unternehmen“), ein innovatives Medizintechnikunternehmen, das die Lagerung und Verwaltung temperaturempfindlicher Medikamente revolutioniert, freut sich bekannt zu geben, dass es eine Vertriebsvereinbarung, datiert mit 25. August 2026 (die „Vertriebsvereinbarung“) mit CenterWell Pharmacy, Inc. („CenterWell“), der Pharmadienstleistungsmarke von Humana Inc., einem
The post TempraMed gibt Vertriebsvereinbarung mit CenterWell Pharmacy®, der Pharmadienstleistungsmarke von Humana, bekannt appeared first on IRW-Press....
|
|
|
|
|
15.09.26 - 14:33
|
Quantum Health Names Dr. Susan Mani as Chief Medical Officer (Business Wire)
|
|
|
Physician executive brings decades of experience in value-based care and population health to Quantum Health's clinical leadership teamDUBLIN, Ohio--(BUSINESS WIRE)--Quantum Health, the industry-leading healthcare navigation company, today announced the appointment of Susan Mani, M.D., as Chief Medical Officer. Dr. Mani will shape Quantum Health's clinical strategy, working to improve healthcare experiences, results and affordability for members and clients."Dr. Mani has spent her career proving that better clinical outcomes and lower costs aren't a trade-off,” said Dayne Williams, CEO of Quantum Health. "Her deep expertise in value-based care and population health strategy will be instrumental as we continue to evolve our solutions for employers and members navigating today's increasingly complex healthcare landscape."Prior to joining Quantum Health, Dr. Mani led population health and value-based care initiatives at Humana and LifeBridge Health, driving measurable improvements in hea...
|
|
|
|
|
|
|
|
|
|
|
|
|
02.09.26 - 12:36
|
Humana Board Declares Payment of Quarterly Dividend to Stockholders (Business Wire)
|
|
|
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on November 27, 2026 to stockholders of record as of the close of business on October 30, 2026.
About Humana
Humana (NYSE: HUM) is a leading U.S. healthcare company. Through our Humana insurance services and our CenterWell healthcare services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare and Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com. Contacts
Lisa Stoner
Humana Investor Relations
(502) 580-2652
e-mail: lstamper@humana.com
Mark Taylor
Humana Corporate Communications
(317) 753-0345
e-mail: Mtaylor108@humana.com...
|
|
|
|
|
|
|
|
|
|
|
|